[
  {
    "ts": null,
    "headline": "Charles River Laboratories International, Inc. (CRL): Among the Worst Performing Stocks in S&P 500 So Far in 2025",
    "summary": "We recently published a list of the 11 Worst Performing Stocks in S&P 500 So Far in 2025. In this article, we will take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against other worst performing stocks this year. After a two-year surge of 53%, marking the best performance for the broad […]",
    "url": "https://finnhub.io/api/news?id=f2db62cfedbf8d85a427e258e6ea791d7b15c2d27604303a24f363d889ecbdd4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746056396,
      "headline": "Charles River Laboratories International, Inc. (CRL): Among the Worst Performing Stocks in S&P 500 So Far in 2025",
      "id": 134167032,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "We recently published a list of the 11 Worst Performing Stocks in S&P 500 So Far in 2025. In this article, we will take a look at where Charles River Laboratories International, Inc. (NYSE:CRL) stands against other worst performing stocks this year. After a two-year surge of 53%, marking the best performance for the broad […]",
      "url": "https://finnhub.io/api/news?id=f2db62cfedbf8d85a427e258e6ea791d7b15c2d27604303a24f363d889ecbdd4"
    }
  },
  {
    "ts": null,
    "headline": "Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for",
    "summary": "Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=5ed1a12a5f76400fb99ffaac184cc141af1333382969dbad5bf669db7516a472",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746021681,
      "headline": "Analysts Estimate Charles River Laboratories (CRL) to Report a Decline in Earnings: What to Look Out for",
      "id": 134167033,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "CRL",
      "source": "Yahoo",
      "summary": "Charles River (CRL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=5ed1a12a5f76400fb99ffaac184cc141af1333382969dbad5bf669db7516a472"
    }
  },
  {
    "ts": null,
    "headline": "The Davenport Insider Buying Fund Q1 2025 Commentary",
    "summary": "The Davenport Insider Buying Fund (DBUYX) generated a -5.96% total return in the first quarter of 2025. Click here to read the full commentary.",
    "url": "https://finnhub.io/api/news?id=f52f52127c7c16e9540f88b16ba300fdfda063ecef2823ccdab8e6bcd061f6ca",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1746013500,
      "headline": "The Davenport Insider Buying Fund Q1 2025 Commentary",
      "id": 134146439,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1322205526/image_1322205526.jpg?io=getty-c-w1536",
      "related": "CRL",
      "source": "SeekingAlpha",
      "summary": "The Davenport Insider Buying Fund (DBUYX) generated a -5.96% total return in the first quarter of 2025. Click here to read the full commentary. ",
      "url": "https://finnhub.io/api/news?id=f52f52127c7c16e9540f88b16ba300fdfda063ecef2823ccdab8e6bcd061f6ca"
    }
  }
]